Cargando…
In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor
BACKGROUND: Childhood peroxisomal disorders and leukodystrophies are devastating diseases characterized by dysfunctional lipid metabolism. Plasmalogens (ether glycerophosphoethanolamine lipids) are decreased in these genetic disorders. The biosynthesis of plasmalogens is initiated in peroxisomes but...
Autores principales: | Wood, Paul L, Khan, M Amin, Smith, Tara, Ehrmantraut, Greg, Jin, Wei, Cui, Wei, Braverman, Nancy E, Goodenowe, Dayan B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238230/ https://www.ncbi.nlm.nih.gov/pubmed/22008564 http://dx.doi.org/10.1186/1476-511X-10-182 |
Ejemplares similares
-
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease
por: Wood, Paul L, et al.
Publicado: (2011) -
Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction
por: Wood, Paul L, et al.
Publicado: (2011) -
Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata
por: Fallatah, Wedad, et al.
Publicado: (2020) -
Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011
por: Smith, Tara, et al.
Publicado: (2022) -
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
por: Senanayake, Vijitha, et al.
Publicado: (2019)